Professor of Radiation Oncology University of Colorado Cancer Center
Radiation Oncology
Dr. David Raben, MD
|
|
Give Review
David Raben works in the field of Radiation Oncology. He went to Wake Forest School of Medicine. He received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". David Raben is also published. He has 97 publications published. The lastest publication: "Dual coupling of the alpha-thrombin receptor to signal-transduction pathways involving phosphatidylinositol and phosphatidylcholine metabolism.' David Raben, MD accepts all Medicare patients.
Publications
- Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck Squamous cell carcinoma.
- Survival Outcomes of Dose-Escalated External Beam Radiotherapy (DE-EBRT) Versus Combined Brachytherapy for Intermediate- and High-Risk Prostate Cancer Using the Nation...
- Molecular Determinants of Radiation Response in Non-Small Cell Lung Cancer.
- Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate Cancer.
- A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma.
- A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Local...
- A Multicenter Review of Contralateral Submandibular Gland Sparing in Locally Advanced Oropharyngeal Cancers: Is is Safe?
- Hedgehog signaling drives radioresistance and stroma-driven tumor repopulation in head and neck squamous Cancers.
- Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate Cancer.
- The impact of definitive local therapy for lymph node-positive prostate Cancer: a population-based study.
- The prognostic significance of Gleason scores in metastatic prostate Cancer.
- A patient tumor transplant model of squamous cell Cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins.
- Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis.
- Sparing the larynx and esophageal inlet expedites feeding tube removal in patients with stage III-IV oropharyngeal Squamous cell carcinoma treated with intensity-modul...
- Biologically Targeted Therapies Plus Chemotherapy Plus Radiotherapy in Stage III Non-Small-Cell Lung Cancer: A Case of the Icarus Syndrome?
- The Antioxidant, MnTE-2-PyP, Prevents Side-Effects Incurred by Prostate Cancer Irradiation.
- Microcystic adnexal Carcinoma of the face treated with radiation therapy: A case report and review of the literature.
- Feasibility of EASE: a psychosocial program to improve symptom management in head and neck Cancer patients.
- Salivary Gland Cancer.
- Phospholipid metabolism and nuclear envelope signaling.
- Sustained increase in 1,2-diacylglycerol precedes DNA synthesis in epidermal-growth-factor-stimulated fibroblasts. Evidence for stimulated phosphatidylcholine hydrolysis.
- Alpha-thrombin stimulates nuclear diglyceride levels and differential nuclear localization of protein kinase C isozymes in IIC9 Cells.
- Molecular species analysis of mitogen-stimulated 1,2-diglycerides in fibroblasts. Comparison of alpha-thrombin, epidermal growth factor, and platelet-derived growth fa...
- Carbachol stimulates a different phospholipid metabolism than nerve growth factor and basic fibroblast growth factor in PC12 Cells.
- Kinetic analysis of 1,2-diacylglycerol mass levels in cultured fibroblasts. Comparison of stimulation by alpha-thrombin and epidermal growth factor.
- Activation of phospholipase D by alpha-thrombin or epidermal growth factor contributes to the formation of phosphatidic acid, but not to observed increases in 1,2-diac...
- Sustained activation of extraCellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase.
- Dual coupling of the alpha-thrombin receptor to signal-transduction pathways involving phosphatidylinositol and phosphatidylcholine metabolism.
- Ablation of Goalpha overrides G1 restriction point control through Ras/ERK/cyclin D1-CDK activities.
- Ras-stimulated extraCellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regul...
- Phosphatidylinositol 3-kinase activity regulates alpha -thrombin-stimulated G1 progression by its effect on cyclin D1 expression and cyclin-dependent kinase 4 activity.
- Locoregional recurrence of an HPV-positive Squamous cell carcinoma of the head and neck.
- Emerging applications of stereotactic body radiation therapy for head and neck Cancer.
- Back to the future: a proton pro/con.
- Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck Squamous cell carcinoma: a phase II, randomized, double-blind, placebo-controlled study.
- Caspase 3-mediated stimulation of tumor cell repopulation during Cancer radiotherapy.
- Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck Squamous cell carcinoma cells.
- Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung Cancer.
- Combinatorial effect of maytansinol and radiation in Drosophila and human Cancer cells.
- Stereotactic body radiation therapy for melanoma and renal Cell carcinoma: impact of single fraction equivalent dose on local control.
- p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal Cancer.
- Dosimetric effect of online image-guided anatomical interventions for postprostatectomy Cancer patients.
- Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck Cancer.
- Impact of anatomical interventions on the localization of post-prostatectomy Cancer patients.
- Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies.
- Survival and patterns of relapse in patients with oral tongue Cancer.
- Radiotherapy plus cetuximab for locoregionally advanced head and neck Cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-indu...
- Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.
- Select cyclopentenone prostaglandins trigger glutathione efflux and the role of ABCG2 transport.
- Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to Prostate for intermediate- and high-risk Prostate...
- Results of a phase I trial of 12 patients with locally advanced Pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of ...
- Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes Bladder cancer cells to cisplatin in a dose...
- Favorable toxicity and biochemical control using real-time inverse optimization technique for Prostate brachytherapy.
- Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil Cancer: results of a prospective management a...
- Integrating biologically targeted therapy in head and neck Squamous cell carcinomas.
- Pharmacokinetic-directed dosing of vandetanib and docetaxel in a mouse model of human Squamous cell carcinoma.
- Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal Cancer: a phase II trial.
- High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the Bladder: implications for screening trials.
- Head and neck Cancer.
- Improved survival in patients with Stage III-IV Head and neck Cancer treated with radiotherapy as primary local treatment modality.
- Outcomes of patients with n3 Neck nodes treated with chemoradiation.
- Effect of radiation techniques in treatment of oropharynx Cancer.
- Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck Cancer: a SEER database analysis.
- Poor prognosis in patients with stage I and II oral tongue Squamous cell carcinoma.
- Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck Cancer.
- The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium.
- Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck Squamous cell carcinoma and non-small cell lung carcinoma.
- Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human...
- A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck Cancer patients.
- Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung Cancer cell lines correla...
- Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine ...
- Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.
- Toward a unified target theory in oncology.
- Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in Carcinomas with chromosome 11q13 amplification.
- Metastatic malignant melanoma from an unknown primary presenting as a large axillary mass.
- Current radiation therapy management issues in oral cavity Cancer.
- Radiotherapy plus cetuximab for Squamous-cell carcinoma of the head and neck.
- ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy.
- Vascular-targeting agents and radiation therapy in lung Cancer: where do we stand in 2005?
- Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell Cancer treated with definitive radiotherapy: a secondary...
- Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma.
- New radiation therapy techniques for the treatment of head and neck Cancer.
- The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung Cancer.
- Emerging role of EGFR-targeted therapies and radiation in head and neck Cancer.
- Angiogenesis inhibitors: a rational strategy for radiosensitization in the treatment of non-small-cell lung Cancer?
- Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, a...
- Targeted therapies for non-small-cell lung Cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
- Targeted therapies and radiation for the treatment of head and neck Cancer: are we making progress?
- Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003.
- Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not know.
- Interference with EGFR signaling: paradigm for improving radiation response in Cancer treatment.
- External beam radiotherapy in bone metastatic prostate Cancer: impact on patients'' pain relief and quality of life.
- Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Ire...
- ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy ...
- Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck Cancer according to the National Cancer Data Base.
- Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.
Schools
Wake Forest University School of Medicine
University Hi J a Burns School Med
Duke University
Procedures Preformed
- Intensity-Modulated Radiation Therapy (IMRT)
- Prostate Brachytherapy
- Stereotactic Body Radiotherapy (SBRT)
Conditions Treated
- Bladder Cancer
- Pancreatic Cancer
- Prostate Cancer
- Skin Cancer
- View All
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Bronze Direct CACA IN HIX
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Cofinity PPO
- CoreSource
- Coventry Health Care
- First Choice Health
- First Health (Coventry Health Care) PPO
- Golden Rule
- HealthSmart
- Humana
- MedHealthInsurance
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- Rocky Mountain Health Plans HMO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
University of Hawaii -
Wake Forest School of Medicine
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1982711727 | |
| NPPES Provider LastName | RABEN | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 272.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982711727 |
| Last Name Of The Provider | RABEN |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Laurie E. Gaspar, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Rachel Rabinovitch, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Arthur K. Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine M. Fisher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian D. Kavanagh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracey Schefter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Krishna Reddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chad G. Rusthoven, MD |